UT-Southwestern Medical Center: Gold Nanoparticles Reverse Brain Deficits in Multiple Sclerosis, Parkinson's
February 13, 2024
February 13, 2024
DALLAS, Texas, Feb. 13 (TNSres) -- The University of Texas Southwestern Medical Center issued the following news release:
* * *
Phase two clinical trials suggest experimental treatment could improve patient outcomes
* * *
Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson's disease (PD) significantly reversed de . . .
* * *
Phase two clinical trials suggest experimental treatment could improve patient outcomes
* * *
Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson's disease (PD) significantly reversed de . . .